CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse
Clinical trial NCT00003131 · COMPLETED
Trial details
- NCT number
- NCT00003131
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1997-02-01
- Primary completion
- 2002-02-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.